Keyphrases
Blood Flow
100%
Exercise Capacity
100%
Flow Function
100%
Vascular Function
100%
Cystic Fibrosis
100%
Exercise Intolerance
30%
PDE5 Inhibitors
23%
Endothelial Function
23%
Endothelial Dysfunction
15%
Vascular Biology
7%
Blood Flow Regulation
7%
Lung Function
7%
Exercise Physiology
7%
Lung Dysfunction
7%
Acute Treatment
7%
Pulmonary Infection
7%
Incomplete Knowledge
7%
Exercise Tolerance
7%
Genetic Disease
7%
Randomized Placebo-controlled Trial
7%
Young Patients
7%
North America
7%
Potential Therapy
7%
Treatment Trials
7%
Acute Experiment
7%
Clinical Manifestations
7%
Systemic Implications
7%
Per Se
7%
Chronic Treatment
7%
During Exercise
7%
Physiological Mechanism
7%
Vascular Pharmacology
7%
Treatment Function
7%
Pulmonary Function
7%
Medicine and Dentistry
Cystic Fibrosis
100%
Blood Flow
100%
Patient with Cystic Fibrosis
62%
Exercise Intolerance
50%
Endothelial Function
37%
Endothelial Dysfunction
25%
Phosphodiesterase V
25%
Lung
25%
Genetic Disorder
12%
Vascular Biology
12%
Placebo
12%
Lung Function
12%
Lung Infection
12%
Exercise Tolerance
12%
Phosphodiesterase V Inhibitor
12%
Exercise Physiology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Phosphodiesterase V
15%
Endothelial Dysfunction
15%
Lung Infection
7%
Phosphodiesterase V Inhibitor
7%
Genetic Disorder
7%
Placebo
7%